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Objectives. We evaluated the use of fluorine-18 fluorodeoxyglu-
cose (FDG) and single-photon emission computed tomography
(SPECT) to predict improvement of left ventricular ejection
fraction (LVEF) after revascularization.
Background. FDG SPECT has recently been proposed for
assessment of myocardial viability. However, FDG SPECT still
awaits validation in terms of predicting improvement of contrac-
tile function after revascularization in patients with poor left
ventricular (LV) function.
Methods. Fifty-five patients with contractile dysfunction (in-
cluding 22 with LVEF <30%) underwent FDG SPECT during
hyperinsulinemic glucose clamping and early thallium-201
SPECT (to assess perfusion). Improvement of LV function was
evaluated 3 months after revascularization with echocardiography
and radionuclide ventriculography.
Results. The 55 patients were arbitrarily classified into two
groups: 19 with three or more viable, dysfunctional segments on
FDG SPECT and 36 with less than three viable, dysfunctional
segments. LVEF increased significantly in the first group, from
28 6 8% (mean 6 SD) before to 35 6 9% (p < 0.01) after
revascularization. In the second group, LVEF remained un-
changed after revascularization (45 6 14% vs. 44 6 14%, p 5 NS).
The 22 patients with severely depressed LV function were simi-
larly classified into two groups: 14 with three or more viable
segments on FDG SPECT in whom LVEF improved significantly
(25 6 6% vs. 32 6 6%) and 8 with less than three viable segments
in whom LVEF remained unchanged (24 6 6% vs. 25 6 6%).
Conclusions. This study shows that FDG SPECT can identify
patients in whom LV function improves after revascularization.
Because SPECT is widely available, this technique may contribute
to more routine use of FDG for determination of viability.
(J Am Coll Cardiol 1997;30:377–83)
©1997 by the American College of Cardiology
Heart failure is an increasing problem in cardiology because of
its increasing incidence over the past decade. In patients with
extensive coronary artery disease, impaired left ventricular
(LV) function is not necessarily an irreversible process because
recovery of LV function after revascularization has been
demonstrated, even in asynergic myocardial regions. In the
early 1970s, different methods (including inotropic catechol-
amine infusions [1], nitroglycerin [2] and post–extrasystolic
potentiation [3]) were proposed for identifying viable myocar-
dium and predicting functional recovery. The concepts of
hibernation and repetitive stunning were introduced to explain
such situations of reversibly impaired LV function (4,5).
Rahimtoola (4) initially described hibernation as a chronic
state of myocardial hypoperfusion accompanied by chronic
contractile dysfunction that can be reversed after revascular-
ization. More recently, this hypothesis was challenged by
Vanoverschelde et al. (5) who pointed out that many segments
with chronic contractile dysfunction that improved after revas-
cularization had (near-) normal perfusion. They stated that
repeated attacks of ischemia may also result in chronic con-
tractile dysfunction, whereas rest perfusion may be normal in
such cases.
Currently, positron emission tomography (PET) with
fluorine-18 fluorodeoxyglucose (FDG) is considered one of the
most accurate techniques for identifying viable myocardium
(6,7). Reversibility of regional wall motion abnormalities after
revascularization was demonstrated in regions with normal
perfusion (indicating repetitive stunning [5]) or in hypoper-
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fused regions with relatively preserved FDG uptake (flow–
metabolism mismatch, representing hibernating myocardium
[4]), whereas regions with hypoperfusion and decreased FDG
uptake (flow–metabolism match, indicating scar tissue) showed
no recovery of function (8–18).
In addition, improvement of global LV function was seen in
patients with viable myocardium on FDG PET (15,17,18).
However, the majority of these studies included patients with
only mild to moderate depressed LV function, whereas preop-
erative evaluation of viability bears most clinical relevance in
patients with severely depressed LV function. In these pa-
tients, the perioperative risk for complications is high (19), but
the potential gain in terms of prognosis is also high (20).
Relatively few PET devices are available for clinical use.
Therefore, several laboratories have evaluated the feasibility of
imaging myocardial FDG uptake with single-photon emission
computed tomography (SPECT) using 511-keV collimators
(21–26). However, no data are available on the diagnostic
value of FDG SPECT for predicting functional recovery after
revascularization. Hence, the aim of the present study was to
evaluate whether FDG SPECT can predict improvement of
regional and global LV function after revascularization. In
addition, a subset of patients with poor LV function (LV
ejection fraction [LVEF] ,30%) were included.
Methods
Study patients. We prospectively studied 55 consecutive
patients referred for coronary revascularization, 10 of whom
had been included in a previous report (23) comparing FDG
SPECT with low dose dobutamine echocardiography and
thallium-201 (Tl-201) stress–reinjection. All patients had re-
gional wall motion abnormalities at rest observed on ventricu-
lography and two-dimensional echocardiography. Forty-five
patients (82%) underwent coronary artery bypass graft surgery
(CABG), and 10 (18%) had percutaneous transluminal coro-
nary angioplasty (PTCA). The SPECT studies were performed
in patients already scheduled for revascularization, and the
results did not influence patient management.
Study protocol. All patients underwent early rest Tl-201
SPECT to evaluate myocardial perfusion, followed by FDG
SPECT after placement of a hyperinsulinemic euglycemic
clamp. Improvement of regional wall motion was determined
from serial rest echocardiograms before and 3 months after
revascularization. To assess improvement of LVEF, 18 pa-
tients had radionuclide ventriculography before and after
revascularization; in the remaining 37 patients, LVEF was
calculated from the echocardiograms.
The SPECT studies were performed on the same day.
Cardiac medication was continued during the study. Medica-
tion included beta-adrenergic blocking agents (n 5 31),
angiotensin-converting enzyme inhibitors (n 5 31), nitrates
(n 5 37), calcium antagonists (n 5 17), diuretic drugs (n 5 13)
and aspirin (n 5 49). All patients were clinically stable during
the study; none had unstable angina or myocardial infarction
between revascularization and the scintigraphic studies or after
the intervention. Each patient gave informed consent to the
study protocol, which was approved by the ethics committees
of the participating hospitals.
Tl-201 SPECT. To delineate regional myocardial perfu-
sion, rest Tl-201 SPECT was performed as described previ-
ously (27). Briefly, a single dose of 111-MBq (3 mCi) Tl-201
chloride was administered intravenously at rest. Imaging was
started 10 to 15 min after injection. A large field of view
rotating dual-head gamma camera (ADAC Laboratories) was
used, equipped with a low energy high resolution collimator.
The energy was centered on the 89-keV photon peak with a
20% window and on the 167-keV photon peak with a 20%
window. The dual-head gamma camera system was rotated
over 360°, collecting 64 views for 30 s each. Data were stored
in a 64 3 64, 16-bit matrix. From the raw scintigraphic data,
6-mm thick (1 pixel) transaxial slices were reconstructed by
filtered backprojection using a Hanning filter (cutoff frequency
0.63 cycle/cm). Slices were not corrected for attenuation.
Further reconstruction yielded long- and short-axis projections
perpendicular to the heart axis.
FDG SPECT. After an overnight fast, subjects underwent a
placement of hyperinsulinemic glucose clamp (28) to standard-
ize metabolic conditions throughout FDG SPECT (see Hyper-
insulinemic euglycemic clamping). FDG (185 MBq [5 mCi])
was injected after 60 min of clamping; another 45 min was
allowed for myocardial FDG uptake (29,30). Data acquisition
was performed with the same camera system as described for
Tl-201, using the same acquisition time per projection (30 s)
and the same matrix (64 3 64, 16 bit). For the detection of
511-keV photons, specially designed collimators were used
(van Mullekom, Nuclear Fields, Boxmeer, The Netherlands)
(31). Reconstruction of data was also identical to that for
Tl-201 SPECT.
Hyperinsulinemic euglycemic clamping. For this purpose,
two catheters were placed in the left and right antecubital
veins. One catheter was used for separate infusions of glucose
and insulin. The contralateral catheter was used for the
administration of FDG and to draw plasma samples to monitor
glucose levels. Insulin (Human Velosulin, Novo Nordisk,
100 IU/ml) in 0.65% sodium chloride was used. To prevent
adhesion of insulin to the infusion system, 3.8 ml of human
albumin (20% Human Albumin, CLB) was added. The insulin
infusion rate was 100 mU/kg per h and was not changed
throughout clamping to achieve a hyperinsulinemic state.
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
FDG 5 fluorine-18 fluorodeoxyglucose
LV 5 left ventricle, left ventricular
LVEF 5 left ventricular ejection fraction
PET 5 positron emission tomography (tomographic)
PTCA 5 percutaneous transluminal coronary angioplasty
SPECT 5 single-photon emission computed tomography (tomographic)
Tl-201 5 thallium-201
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Glucose infusion (500 ml of 20% glucose with 20 ml of 14.9%
potassium chloride to prevent hypokalemia) was started at a
rate of 6 mg/kg body weight per min and was adjusted every
10 min to maintain normoglycemia. This was done according to
acutely determined plasma glucose levels.
Image analysis. The FDG and Tl-201 SPECT data were
analyzed as described previously (23). Briefly, circumferential
profiles (60 radii, highest pixel activity/radius) from the avail-
able FDG data, and Tl-201 short-axis slices were generated
(after alignment of the Tl-201 and FDG short-axis slices) and
displayed in a polar map format. The polar maps were divided
into 13 segments, as demonstrated in Figure 1 (for exact
comparison with the 13 echocardiographic segments, see be-
low).
The segment with the highest Tl-201 uptake was considered
normal. The activity of this area was normalized to the mean
activity of the same area of a normal database (obtained in
nine normal male subjects, mean [6SD] age 43 6 10 years
[21]), and all other polar map data were adjusted correspond-
ingly. The area of normal perfusion was projected on the FDG
polar map, and the same normalization procedure was fol-
lowed. For this purpose a database of FDG activities in the
aforementioned normal subjects was used (21). Segments with
a Tl-201 activity ,2 SD below the normal reference value were
considered abnormal. Tl-201 and FDG activities were ex-
pressed as percentage of the corresponding normal reference
values.
Definition of myocardial viability. A segment was consid-
ered viable if the perfusion was normal, or if the FDG uptake
was relatively increased (.7%, as previously described [23]) in
a perfusion defect (flow–metabolism mismatch). Segments
with a perfusion defect and concordantly decreased FDG
uptake (flow–metabolism match) were considered necrotic.
Assessment of improvement of regional dysfunction. Re-
gional wall motion was assessed by rest echocardiography
before and after revascularization. Echocardiographic images
were recorded on videotape. Four standard views of the LV
were obtained: parasternal long- and short-axis views and
apical two- and four-chamber views. The images were reviewed
off-line, and consensus was achieved by two observers (J.H.C.,
P.M.F.) unaware of the SPECT data. For exact alignment of
the echocardiographic and SPECT data, the LV was divided
into 13 comparable segments, as previously reported (23): one
apical segment, six distal segments (anterior, anterolateral,
inferolateral, inferior, inferoseptal and anteroseptal) and six
basal segments (comparable to the distal segments) were
identified (see also Fig. 1). For the echocardiographic data,
these segments were derived from the parasternal long- and
short-axis views; for the SPECT data, they were derived from
the polar maps.
Both inward wall motion and wall thickening were analyzed.
Each segment was assigned a wall motion score of 0 to 3:
normal 5 0; hypokinetic 5 1 (decreased endocardial excursion
and systolic wall thickening); akinetic 5 2 (absence of endo-
cardial excursion and systolic wall thickening); and dyski-
netic 5 3 (paradoxic outward movement in systole). The
preinterventional and postinterventional images were com-
pared on a segmental basis. Postinterventional improvement of
regional wall motion was considered present if systolic thick-
ening (hypokinesia or normokinesia) was detected in a seg-
ment that was akinetic or dyskinetic at baseline or if normal
wall motion was detected in segments that were hypokinetic at
baseline. Only segments that were successfully revascularized
were analyzed on the basis of a review of the CABG and PTCA
reports. Wall thickening was primarily utilized for the classifica-
tion of septal wall motion, thereby preventing the problem of
paradoxic septal motion after CABG (32). Previous results from
our laboratory (33) showed a high interobserver (84%) and
intraobserver (87%) concordance of rest wall motion analysis.
Assessment of improvement of global ventricular function.
LVEF (before and after revascularization) was assessed by
radionuclide ventriculography in 18 patients. Radionuclide
ventriculography was performed at rest with the patient in
the supine position after administration of 740 MBq of
technetium-99m. Images were acquired with a small field of
view gamma camera (Orbiter, Siemens Corp.) oriented in the
45° left anterior oblique position with a 5° to 10° caudal tilt.
LVEF was calculated from the 45° left anterior oblique view by
an automated technique. In 37 patients, LVEF was calculated
by cross-sectional echocardiography utilizing the apical bipla-
nar Simpson’s technique (34). Improvement of global function
after revascularization was defined arbitrarily as an increase in
LVEF .5%.
Statistical analysis. Results are expressed as mean value 6
SD. Patient data were compared using the Student t test for
paired and unpaired data when appropriate. Comparison of
proportions was performed using chi-square analysis. A p value
,0.05 was considered significant.
Results
Patient characteristics. The clinical characteristics of the
study patients are presented in Table 1. Fifty-one patients
(93%) had a previous infarction. The time interval of infarc-
tion to the SPECT study was .1 month in 93% of patients.
Eight patients had diabetes mellitus type II that was well
regulated with oral hypoglycemic agents. All patients had
significant coronary artery disease on angiography (.50%
Figure 1. Thirteen-segment model used for SPECT and echocardiog-
raphy: 1 5 basal anterior; 2 5 basal anterolateral; 3 5 basal postero-
lateral; 4 5 basal inferior; 5 5 basal inferoseptal; 6 5 basal antero-
septal; 7 5 distal anterior; 8 5 distal anterolateral; 9 5 distal
posterolateral; 10 5 distal inferior; 11 5 distal inferoseptal; 12 5 distal
anteroseptal; 13 5 apex.
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reduction in lumen diameter of at least one major epicardial
coronary artery). They had an average of 2.5 6 0.7 stenosed
vessels. The 55 patients had a mean LVEF of 39 6 14%, 22 of
whom had an LVEF ,30% (mean LVEF 24 6 6%).
Baseline characteristics. Of the 715 segments analyzed by
echocardiography, 410 (57%) had normal and 305 (43%)
abnormal wall motion before revascularization. The mean
number of abnormal segments/patient was 5.5 6 3.1. Twenty-
four segments were excluded from analysis because of inade-
quate revascularization (based on review of the PTCA/CABG
reports). Thus, 281 dysfunctional segments were analyzed: 128
(46%) segments were hypokinetic, and 153 (54%) were aki-
netic/dyskinetic. Forty-nine (17%) dysfunctional segments had
normal perfusion on Tl-201 SPECT.
Prediction of improvement of regional contractile function
by FDG SPECT. Using recovery of wall motion abnormalities
on echocardiography as the reference standard for the pres-
ence of viable tissue, the 281 segments with abnormal wall
motion at baseline were classified into two groups: segments
with improvement after revascularization (group I, n 5 94) and
segments without improvement (group II, n 5 187). In group
I the segmental wall motion score decreased from 1.59 6 0.49
to 0.49 6 0.50, whereas in group II it remained unchanged (by
definition).
Twenty-eight of the segments in group I had normal
perfusion, 52 had a flow–metabolism mismatch, and 14 had a
match. In group II, 21 segments had normal perfusion, 46 had
a mismatch, and 120 a match (p , 0.01 vs. group I). The
sensitivity and specificity were thus 85% and 75%, with a
positive and negative predictive value of 63% and 91%,
respectively. Examples of two patients, one with a match and
one with a mismatch, are demonstrated in Figures 2 and 3.
Prediction of functional recovery in different subgroups.
The sensitivity and specificity for the detection of functional
recovery were determined in different subsets of segments
(Table 2): 1) The segments were divided according to severity
of wall motion abnormalities (hypokinetic vs. akinetic/
dyskinetic). In hypokinetic segments, the sensitivity and spec-
ificity were 82% and 66%, respectively. In akinetic/dyskinetic
segments, the sensitivity and specificity were 87% and 84%,
respectively. 2) The segments were classified according to the
different myocardial regions. The sensitivity and specificity for
the detection of functional recovery in the apical, anterior and
lateral regions were 86% and 76%, respectively, whereas in the
inferior and septal regions, these values were 84% and 75%,
Figure 2. Two short-axis slices from a patient with a flow–metabolism
match. Both Tl-201 (left) and FDG uptake (right) are virtually absent
in the anterior wall. On rest echocardiography, the anterior wall was
akinetic before revascularization and did not improve in wall motion
after intervention. Rest LVEF was 24% before and 22% after revas-
cularization.
Figure 3. Two short-axis slices from a patient with a flow–metabolism
mismatch. In the inferoseptal region, Tl-201 uptake (left) is decreased,
with preserved FDG uptake (right) in the septal region. Rest echo-
cardiography revealed akinesia in the inferior and septal regions
before revascularization. After intervention, wall motion improved in
the septal region. LVEF improved from 29% to 37% after revascular-
ization.
Table 1. Clinical Characteristics of 55 Study Patients
Male/female 49/6
Age (yr) 62 6 10
Previous infarction 51 (93%)
Q wave on ECG 36 (71%)
Anterior 18 (50%)
Inferior 18 (50%)
Angina, NYHA class 2.2 6 0.8
Functional NYHA class 1.9 6 0.9
Coronary disease
1-vessel disease 7 (13%)
2-vessel disease 11 (20%)
3-vessel disease 37 (67%)
LVEF (%) 39 6 14
Previous CABG 11 (20%)
Previous PTCA 4 (7%)
Data presented are mean value 6 SD or number (%) of patients. CABG 5
coronary artery bypass graft surgery; ECG 5 electrocardiogram; LVEF 5 left
ventricular ejection fraction; NYHA 5 New York Heart Association; PTCA 5
percutaneous transluminal coronary angioplasty.
Table 2. Sensitivity and Specificity of Fluorine-18
Fluorodeoxyglucose Single-Photon Emission Computed Tomography
for Predicting Functional Recovery After Revascularization in
Different Subsets of Segments
Sensitivity
[% (no. of segs)]
Specificity
[% (no. of segs)]
Total group (n 5 281) 85 (80/94) 75 (141/187)
Hypokinetic segs (n 5 128) 82 (32/39) 66 (59/89)
Akinetic/dyskinetic segs (n 5 153) 87 (48/55) 84 (82/98)
Ant/apic/lat segs (n 5 139) 86 (44/51) 76 (67/88)
Inf/sept segs (n 5 142) 84 (36/43) 75 (74/99)
Segs of pts with LVEF $30%
(n 5 109)
80 (33/41) 81 (55/68)
Segs of pts with LVEF ,30%
(n 5 172)
89 (47/53) 72 (86/119)
Ant 5 anterior; apic 5 apical; Inf 5 inferior; lat 5 lateral; LVEF 5 left
ventricular ejection fraction; pts 5 patients; segs 5 segments; sept 5 septal.
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respectively. 3) The segments were classified according to
LVEF (LVEF $30% or ,30%; 22 patients had LVEF ,30%).
The sensitivity and specificity in segments of patients with
LVEF $30% were 80% and 81%, respectively. In the seg-
ments of patients with LVEF ,30%, these values were 89%
and 72%, respectively.
Effect of revascularization on global LV function. The
patients were arbitrarily classified into two groups: group A
included 19 patients with three or more viable, dysfunctional
segments on FDG SPECT; group B included 36 patients with
two or less viable, dysfunctional segments.
LVEF increased significantly in group A, from 28 6 8%
before to 35 6 9% (p , 0.01) after revascularization. In group
B, LVEF remained unchanged after revascularization (45 6
14% vs. 44 6 14%, p 5 NS). We then focused on the patients
(n 5 22) with LVEF ,30% because improvement of LVEF
has the most clinical relevance in this patient group (Fig. 4). In
patients (n 5 14) with three or more viable segments, LVEF
improved significantly, from 25 6 6% to 32 6 6% (p , 0.01).
Conversely, in patients (n 5 8) with two or less viable
segments, LVEF remained unchanged (24 6 6% vs. 25 6 6%,
p 5 NS). When an improvement of LVEF .5% was consid-
ered significant, FDG SPECT correctly identified 12 (100%) of
12 patients with improved LVEF as having enough viable
myocardium (three or more viable segments) to allow im-
provement of global LV function. Similarly, 8 (80%) of 10
patients with no improvement in LVEF were identified as
having no or too little viable myocardium (two or less viable
segments) to allow recovery of global LV function.
Discussion
This study expands the earlier studies with FDG SPECT
(21–26) and demonstrates that semiquantitative FDG SPECT
can predict reversibility of contractile function after revascu-
larization. Significant improvement of global LV function was
observed in patients with three or more viable segments on
FDG SPECT.
Findings of the present study. In the present study, 33% of
segments with abnormal wall motion improved after revascu-
larization. The segments that improved in function demon-
strated either normal perfusion, possibly representing repeti-
tive stunning (5), or a flow–metabolism mismatch, most likely
representing hibernation (4). The majority of segments with-
out functional improvement showed a flow–metabolism match,
suggesting scar tissue (6,7). The sensitivity and specificity were
85% and 75%, respectively, with a positive and negative
predictive value of 63% and 91%, respectively. The results
obtained with FDG SPECT are in line with previous results
obtained with FDG PET. Reanalysis of the available data on
FDG PET predicting functional recovery after revasculariza-
tion showed sensitivities ranging from 71% to 100% (weighted
mean 88%) and specificities ranging from 38% to 86%
(weighted mean 72%) (Table 3) (8–16).
Table 3 also shows that the majority of the studies did not
include many patients with severely depressed LV function. In
the present study, 22 patients with poor LVEF were included;
Figure 4. LVEF before (solid bars) and after revascularization
(hatched bars) in patients with LVEF ,30%. In patients (n 5 14,
group I) with three or more viable segments on FDG SPECT, LVEF
increased from 25 6 6% to 32 6 6% (p , 0.01). Conversely, in patients
(n 5 8, group II) with two or less viable segments, LVEF remained
unchanged (24 6 6% vs. 25 6 6%, p 5 NS).
Table 3. Sensitivity and Specificity of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography
for Detecting Improvement in Regional Contractile Function After Revascularization*
Study (ref no.)
No. of
Pts
Mean (6SD)
LVEF (%)
Sensitivity
[% (no. of segs)]
Specificity
[% (no. of segs)]
Marwick et al. (8) 16 NA 71 (25/35) 76 (38/50)
Tamaki et al. (9) 20 NA 78 (18/23) 78 (18/23)
Gropler et al. (10) 34 NA 83 (38/46) 50 (35/70)
Tamaki et al. (11) 43 41 (NA) 88 (45/51) 82 (65/79)
Knuuti et al. (12) 43 53 (611) 92 (23/25) 85 (50/59)
Lucignani et al. (13) 14 38 (65) 93 (37/40) 86 (12/14)
Carrel et al. (14) 23 34 (614) 94 (16/17) 50 (3/6)
Tillisch et al. (15) 17 32 (614) 95 (35/37) 80 (24/30)
Tamaki et al. (16) 11 NA 100 (40/40) 38 (6/16)
Weighted mean 88 (277/314) 72 (251/347)
*Data were obtained in nine studies with a total of 221 patients undergoing revascularization (based on reanalysis of
data from references 8 to 16). NA 5 not available; ref 5 reference; other abbreviations as in Table 2.
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the sensitivity and specificity of FDG SPECT were not differ-
ent in these patients, in whom prediction of functional recovery
has the most clinical relevance.
Another important finding of this study was that the
patients with three or more dysfunctional but viable segments
on FDG SPECT improved in global function. These findings
were even more dramatic in the group of patients with LVEF
,30%. This finding corroborates previous data (15,17,18) and
emphasizes that a substantial amount of viable myocardium
needs to be present to establish improvement of global LV
function after revascularization.
Methodologic considerations. In this study, early rest Tl-
201 SPECT was used to measure regional perfusion because
regional FDG uptake should be compared with regional
perfusion. Melin and Becker (27) demonstrated that initial
myocardial uptake of Tl-201 was proportional to regional
perfusion (determined with microspheres), even under isch-
emic conditions.
The FDG SPECT study was performed during hyperinsu-
linemic euglycemic clamping. The clamping technique results
in superior image quality (35), particularly in patients with
diabetes mellitus (36). In addition, the clamping technique
minimizes regional inhomogeneity in myocardial FDG uptake
(37). Moreover, Hariharan et al. (38) recently emphasized that
uptake and retention of FDG in the myocardium is linearly
related to glucose utilization only under steady state condi-
tions, as can be obtained by clamping.
Viability was assessed by comparing regional perfusion with
FDG uptake. However, Tl-201 and FDG have different photon
energies, which may lead to differences in attenuation, espe-
cially in the inferoseptal region of the myocardium. However,
in a study performed in normal subjects (21), it was shown that
no differences between tracer activities occurred in the differ-
ent regions of the myocardium. Moreover, in the present study
we demonstrated that sensitivity and specificity for the detec-
tion of recovery were comparable in the anterior, lateral and
apical regions versus the inferior and septal regions. Both the
previous study (21) and the present one suggest that photon
differences have limited impact on the diagnostic accuracy.
Limitations of the study. The echocardiographic data were
analyzed visually, whereas the SPECT data were analyzed
semiquantitatively. Measuring systolic wall thickening quanti-
tatively with magnetic resonance imaging may allow more
precise comparison between contractile function and SPECT
data (39).
We divided the myocardium into 13 comparable segments,
both on echocardiography and SPECT; nevertheless, some
misalignment between the two techniques may have affected
the diagnostic accuracy of FDG/Tl-201 SPECT in the predic-
tion of functional recovery.
Several aspects of our study may have influenced the
sensitivity and specificity of FDG/Tl-201 SPECT for detecting
improvement after revascularization. We did not perform
angiography or some form of stress testing after the interven-
tion to assess adequate revascularization. Reocclusion may
have prohibited some viable segments to recover and may have
influenced the results.
Functional follow-up was performed 3 months after the
revascularization; some viable segments may need more time
to recover after revascularization. However, the optimal mo-
ment for assessing functional recovery is still controversial; La
Canna et al. (40) showed immediate recovery after revascular-
ization, whereas Vanoverschelde et al. (41) suggested that a
longer time interval is needed for recovery of some viable
segments.
We compared FDG SPECT with rest perfusion as assessed
with rest Tl-201 SPECT. The early rest image was used to allow
assessment of perfusion to discriminate between flow–
metabolism matches and mismatches. Other studies (42–44)
have shown that Tl-201 rest–redistribution imaging can also
identify viable myocardium. Therefore, future studies should
be performed to compare FDG SPECT with Tl-201 rest–
redistribution to establish the exact merits of both techniques
in the prediction of functional recovery after revascularization.
In the present study we reported on the diagnostic accuracy
of FDG SPECT to assess improvement of both regional and
global LV function. For the individual patient, improvement of
global function is more important than improvement of re-
gional function. Moreover, the segments within one patient are
not independent, possibly influencing the results. However, to
allow comparison with published reports on FDG PET (to
compare the relative merits of FDG SPECT and FDG PET in
the prediction of functional recovery after revascularization),
we included the sensitivity/specificity of FDG SPECT to pre-
dict improvement of regional function.
Clinical implications and conclusions. The finding that
FDG SPECT can predict improvement of LV function after a
revascularization procedure has important clinical implica-
tions, especially in patients with severe LV dysfunction. These
patients have a poor long-term survival on medical therapy,
which may improve after surgical revascularization (20), but
also have high surgical risks (19). In the present study we
demonstrated that in patients with three or more viable
segments on FDG SPECT, LVEF increased significantly,
whereas LVEF remained unchanged in patients with less than
three viable segments on FDG SPECT. Therefore, the detec-
tion of dysfunctional but viable myocardium (which is likely to
recover after revascularization) with FDG SPECT may help to
identify patients who will benefit most from a revascularization
procedure.
At present, FDG PET is considered one of the most
accurate techniques for assessing myocardial viability. How-
ever, PET is not widely available for routine clinical use. FDG
SPECT may contribute to a more routine use of FDG imaging
for viability studies, provided that there is routine availability
of 511-keV collimators and optimized distribution of FDG.
Additional studies comparing FDG SPECT with the other
radionuclide techniques (Tl-201 and Tc-99m sestamibi imag-
ing) and stress–echocardiography are needed to establish the
relative merits of these techniques in the prediction of func-
tional recovery.
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